| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNISA990002879670203316 |
|
|
Autore |
BOURGET, Paul <1852-1935> |
|
|
Titolo |
Nos actes nous suivent / Paul Bourget |
|
|
|
|
|
Pubbl/distr/stampa |
|
|
|
|
|
|
Descrizione fisica |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Collocazione |
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Nota di contenuto |
|
|
|
|
|
|
2. |
Record Nr. |
UNINA9911074369703321 |
|
|
Titolo |
Pan American Highways Congress. Message from the President of the United States, transmitting a report by the Secretary of State concerning a Pan American Highways Congress, to meet at Buenos Aires on May 22, 1925, together with copies of letters from the Acting Secretary of Commerce ... January 22 (calendar day, January 24), 1925. -- Referred to the Committee on Foreign Relations and ordered to be printed |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Washington, DC : , : [publisher not identified], , 1925 |
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (8 pages) |
|
|
|
|
|
|
Collana |
|
Senate document / 68th Congress, 2nd session. Senate ; ; no. 189 |
[United States congressional serial set] ; ; [serial set no. 8413] |
|
|
|
|
|
|
|
|
Altri autori (Persone) |
|
CoolidgeCalvin <1872-1933.> |
|
|
|
|
|
|
Soggetti |
|
Clergy conferences |
Congresses and conventions |
International relations |
Roads |
Legislative materials. |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
|
|
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Batch processed record: Metadata reviewed, not verified. Some fields updated by batch processes. |
FDLP item number not assigned. |
|
|
|
|
|
|
|
|
3. |
Record Nr. |
UNINA9911098671803321 |
|
|
Titolo |
Clinical trials handbook / / edited by Shayne Cox Gad |
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Hoboken, NJ, : Wiley, c2009 |
|
|
|
|
|
|
|
ISBN |
|
1-282-36844-3 |
9786612368448 |
0-470-46636-7 |
0-470-46635-9 |
|
|
|
|
|
|
|
|
Edizione |
[1st ed.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (1247 p.) |
|
|
|
|
|
|
Collana |
|
Pharmaceutical Development Series ; ; v.8 |
|
|
|
|
|
|
Altri autori (Persone) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
|
|
Soggetti |
|
Drugs - Testing |
Clinical trials |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
Clinical Trials Handbook; Contents; Preface; Contributors; 1 Introduction to Clinical Trials; 2 Regulatory Requirements for Investigational New Drug; 3 Preclinical Assessment of Safety in Human Subjects; 4 Predicting Human Adverse Drug Reactions from Nonclinical Safety Studies; 5.1 History of Clinical Trial Development and the Pharmaceutical Industry; 5.2 Adaptive Research; 6 Organization and Planning; 7 Process of Data Management; 8 Clinical Trials Data Management; 9.1 Clinical Trials and the Food and Drug Administration; 9.2 Phase I Clinical Trials; 9.3 Phase II Clinical Trials |
9.4 Designing and Conducting Phase III Studies9.5 Phase IV: Postmarketing Trials; 9.6 Phase IV and Postmarketing Clinical Trials; 9.7 Regulatory Approval; 9.8 New Paradigm for Analyzing Adverse Drug |
|
|
|
|
|
|
|
|
|
|
|
Events; 10.1 Clinical Trials in Interventional Cardiology: Focus on XIENCE Drug-Eluting Stent; 10.2 Clinical Trials Involving Oral Diseases; 10.3 Dermatology Clinical Trials; 10.4 Emergency Clinical Trials; 10.5 Gastroenterology; 10.6 Gynecology Randomized Control Trials; 10.7 Special Population Studies (Healthy Patient Studies); 10.8 Musculoskeletal Disorders; 10.9 Oncology |
10.10 Pharmacological Treatment Options for Nonexudative and Exudative Age-Related Macular Degeneration10.11 Paediatrics; 10.12 Clinical Trials in Dementia; 10.13 Clinical Trials in Urology; 10.14 Clinical Trials on Cognitive Drugs; 10.15 Bridging Studies in Pharmaceutical Safety Assessment; 10.16 Brief History of Clinical Trials on Viral Vaccines; 11 Methods of Randomization; 12 Randomized Controlled Trials; 13 Cross-Over Designs; 14.1 Biomarkers; 14.2 Biomarkers in Clinical Drug Development: Parallel Analysis of Alzheimer Disease and Multiple Sclerosis; 15 Review Boards |
16 Size of Clinical Trials17 Blinding and Placebo; 18 Pharmacology; 19 Modeling and Simulation in Clinical Drug Development; 20 Monitoring; 21 Inference Following Sequential Clinical Trials; 22 Statistical Methods for Analysis of Clinical Trials; 23 Explanatory and Pragmatic Clinical Trials; 24.1 Ethics of Clinical Research in Durg Trials; 24.2 Ethical Issues in Clinical Research; 25 Regulations; 26 Future Challenges in Design and Ethics of Clinical Trials; 27 Proof-of-Principle/Proof-of-Concept Trials in Drug Development; Index |
|
|
|
|
|
|
Sommario/riassunto |
|
Best practices for conducting effective and safe clinical trials Clinical trials are arguably the most important steps in proving drug effectiveness and safety for public use. They require intensive planning and organization and involve a wide range of disciplines: data management, biostatistics, pharmacology, toxicology, modeling and simulation, regulatory monitoring, ethics, and particular issues for given disease areas. Clinical Trials Handbook provides a comprehensive and thorough reference on the basics and practices of clinical trials. With contributions from a range of |
|
|
|
|
|
|
|
| |